Similarities and Differences of CT Features between COVID-19 Pneumonia and Heart Failure
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Aims: During the COVID-19 epidemic, chest computed tomography (CT) has been highly recommended for screening of patients with suspected COVID-19 because of an unclear contact history, overlapping clinical features, and an overwhelmed health system. However, there has not been a full comparison of CT for diagnosis of heart failure or COVID-19 pneumonia.
Methods: Patients with heart failure ( n =23) or COVID-19 pneumonia ( n =23) and one patient with both diseases were retrospectively enrolled. Clinical information and chest CT images were obtained and analyzed.
Results: There was no difference in ground-glass opacity, consolidation, crazy paving pattern, the lobes affected, and septal thickening between heart failure and COVID-19 pneumonia. However, a less rounded morphology (4% vs. 70%, P=0.00092), more peribronchovascular thickening (70% vs. 35%, P=0.018) and fissural thickening (43% vs. 4%, P=0.002), and less peripheral distribution (30% vs. 87%, P=0.00085) were found in the heart failure group than in the COVID-19 group. Importantly, there were also more patients with upper pulmonary vein enlargement (61% vs. 4%, P=0.00087), subpleural effusion (50% vs. 0%, P=0.00058), and cardiac enlargement (61% vs. 4%, P=0.00075) in the heart failure group than in the COVID-19 group. Besides, more fibrous lesions were found in the COVID-19 group, although there was no statistical difference (22% vs. 4%, P=0.080).
Conclusions: Although there is some overlap of CT features between heart failure and COVID-19, CT is still a useful tool for differentiating COVID-19 pneumonia.
Article activity feed
-
-
SciScore for 10.1101/2020.03.04.20031047: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IRB: This study was reviewed and approved by the Medical Ethical Committee of the Second Xiangya Hospital of Central South University (approval number 2020005), which waived the requirement for patients’ informed consent referring to the CIOMS guideline.
Consent: This study was reviewed and approved by the Medical Ethical Committee of the Second Xiangya Hospital of Central South University (approval number 2020005), which waived the requirement for patients’ informed consent referring to the CIOMS guideline.Randomization not detected. Blinding IMAGINE INTERPRETATION: Two thoracic radiologists blinded to the clinical data reviewed the CT images independently and … SciScore for 10.1101/2020.03.04.20031047: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IRB: This study was reviewed and approved by the Medical Ethical Committee of the Second Xiangya Hospital of Central South University (approval number 2020005), which waived the requirement for patients’ informed consent referring to the CIOMS guideline.
Consent: This study was reviewed and approved by the Medical Ethical Committee of the Second Xiangya Hospital of Central South University (approval number 2020005), which waived the requirement for patients’ informed consent referring to the CIOMS guideline.Randomization not detected. Blinding IMAGINE INTERPRETATION: Two thoracic radiologists blinded to the clinical data reviewed the CT images independently and resolved discrepancies by consensus. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources STATISTICAL ANALYSIS: Statistical analysis was done with SPSS, version 25.0. SPSSsuggested: (SPSS, RRID:SCR_002865)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:There are several limitations of this study. First, this is a retrospective study with limited cases. Most of the patients with COVID-19 enrolled were non-severe cases. Secondly, we mainly focus on the clinical and imaging features at the initial medical contact, while the dynamic changes with appropriate therapy are definitely helpful to differentiate the 2 diseases. In conclusion, during epidemic period, it is essential for doctors to identify the imaging features of COVID-19 and heart failure. Although both diseases can have similar GGO and septal thickening, rounded morphology, peripheral distribution and fibrous lesion were relatively specific in COVID-19. While heart failure usually has more peribronchovascular thickening, fissural thickening, subpleural effusion and cardiac enlargement.
Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-